{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:58:51Z","timestamp":1747169931574,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.rceng.2024.02.008","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T21:29:52Z","timestamp":1708464592000},"page":"189-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-1374","authenticated-orcid":false,"given":"Manuel","family":"Rubio-Rivas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melani","family":"Pesta\u00f1a-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.rceng.2024.02.008_bib0005","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.rceng.2024.02.008_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","article-title":"Mortality and survival in systemic sclerosis: systematic review and meta-analysis","volume":"44","author":"Rubio-Rivas","year":"2014","journal-title":"Semin Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.rceng.2024.02.008_bib0015","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1378\/chest.07-2444","article-title":"High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease","volume":"134","author":"Goldin","year":"2008","journal-title":"Chest."},{"issue":"6","key":"10.1016\/j.rceng.2024.02.008_bib0020","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease","volume":"201","author":"Khanna","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"issue":"11","key":"10.1016\/j.rceng.2024.02.008_bib0025","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"year":"2000","author":"Altman","series-title":"Statistics with confidence. Confidence intervals and statistical guidelines","key":"10.1016\/j.rceng.2024.02.008_bib0030"},{"unstructured":"Wells G., Shea B., O\u2019Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm.","key":"10.1016\/j.rceng.2024.02.008_bib0035"},{"key":"10.1016\/j.rceng.2024.02.008_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"year":"1989","author":"Kahn","series-title":"Statistical Q14 methods in epidemiology","key":"10.1016\/j.rceng.2024.02.008_bib0045"},{"issue":"7414","key":"10.1016\/j.rceng.2024.02.008_bib0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"7109","key":"10.1016\/j.rceng.2024.02.008_bib0055","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"issue":"4","key":"10.1016\/j.rceng.2024.02.008_bib0060","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1136\/annrheumdis-2011-200564","article-title":"Screening for interstitial lung disease in systemic sclerosis: the diagnostic accuracy of HRCT image series with high increment and reduced number of slices","volume":"71","author":"Winklehner","year":"2012","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.rceng.2024.02.008_bib0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/rheumatology\/kes289","article-title":"Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease","volume":"52","author":"Moore","year":"2013","journal-title":"Rheumatology (Oxford)."},{"issue":"12","key":"10.1016\/j.rceng.2024.02.008_bib0070","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1136\/annrheumdis-2014-205637","article-title":"Screening for interstitial lung disease in systemic sclerosis: performance of high-resolution CT with limited number of slices: a prospective study","volume":"73","author":"Frauenfelder","year":"2014","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.rceng.2024.02.008_bib0075","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.semarthrit.2014.09.003","article-title":"Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc-ILD): efficacy of maintenance immunosuppression in responders and non-responders","volume":"44","author":"Iudici","year":"2015","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.rceng.2024.02.008_bib0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1186\/s13075-015-0872-2","article-title":"Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trials","volume":"17","author":"Khanna","year":"2015","journal-title":"Arthritis Res Ther."},{"issue":"4 Suppl 91","key":"10.1016\/j.rceng.2024.02.008_bib0085","first-page":"S111","article-title":"Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease","volume":"33","author":"Moore","year":"2015","journal-title":"Clin Exp Rheumatol."},{"issue":"5","key":"10.1016\/j.rceng.2024.02.008_bib0090","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14397595.2015.1016200","article-title":"Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: a multi-centric study","volume":"25","author":"Ariani","year":"2015","journal-title":"Mod Rheumatol."},{"issue":"8","key":"10.1016\/j.rceng.2024.02.008_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161908","article-title":"Clinical features of idiopathic interstitial pneumonia with systemic sclerosis-related autoantibody in comparison with interstitial pneumonia with systemic sclerosis","volume":"11","author":"Yamakawa","year":"2016","journal-title":"PLoS One."},{"issue":"5","key":"10.1016\/j.rceng.2024.02.008_bib0100","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.chest.2017.06.009","article-title":"Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model","volume":"152","author":"Morisset","year":"2017","journal-title":"Chest."},{"issue":"2","key":"10.1016\/j.rceng.2024.02.008_bib0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semarthrit.2017.03.019","article-title":"Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis","volume":"47","author":"Hax","year":"2017","journal-title":"Semin Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.rceng.2024.02.008_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181692","article-title":"Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease","volume":"12","author":"Le Gouellec","year":"2017","journal-title":"PLoS One."},{"issue":"8","key":"10.1016\/j.rceng.2024.02.008_bib0115","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"12","key":"10.1016\/j.rceng.2024.02.008_bib0120","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/rheumatology\/key213","article-title":"Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial","volume":"57","author":"Sircar","year":"2018","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.rceng.2024.02.008_bib0125","doi-asserted-by":"crossref","first-page":"9468","DOI":"10.1038\/s41598-019-45990-7","article-title":"Performance of a new quantitative computed tomography index for interstitial lung disease assessment in systemic sclerosis","volume":"9","author":"Bocchino","year":"2019","journal-title":"Sci Rep."},{"issue":"6","key":"10.1016\/j.rceng.2024.02.008_bib0130","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.semarthrit.2020.02.015","article-title":"Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: description and prognosis factors","volume":"50","author":"Forestier","year":"2020","journal-title":"Semin Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.rceng.2024.02.008_bib0135","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1007\/s00330-020-06772-2","article-title":"Quantitative computed tomography assessment for systemic sclerosis-related interstitial lung disease: comparison of different methods","volume":"30","author":"Ufuk","year":"2020","journal-title":"Eur Radiol."},{"issue":"2","key":"10.1016\/j.rceng.2024.02.008_bib0140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1177\/2397198320985377","article-title":"Interstitial lung disease in systemic sclerosis quantification of disease classification and progression with high-resolution computed tomography: an observational study","volume":"6","author":"Clukers","year":"2021","journal-title":"J Scleroderma Relat Disord."},{"issue":"5","key":"10.1016\/j.rceng.2024.02.008_bib0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/resp.13988","article-title":"Serum markers of pulmonary epithelial damage in systemic sclerosis-associated interstitial lung disease and disease progression","volume":"26","author":"Stock","year":"2021","journal-title":"Respirology."},{"issue":"5","key":"10.1016\/j.rceng.2024.02.008_bib0150","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: a retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.rceng.2024.02.008_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106689","article-title":"Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease","volume":"191","author":"Watanabe","year":"2022","journal-title":"Respir Med."},{"issue":"4","key":"10.1016\/j.rceng.2024.02.008_bib0160","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00330-020-07293-8","article-title":"Applicability of radiomics in interstitial lung disease associated with systemic sclerosis: proof of concept","volume":"31","author":"Martini","year":"2021","journal-title":"Eur Radiol."},{"issue":"5","key":"10.1016\/j.rceng.2024.02.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04503-2020","article-title":"Computed tomography-based radiomics decodes prognostic and molecular differences in interstitial lung disease related to systemic sclerosis","volume":"59","author":"Schniering","year":"2022","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.rceng.2024.02.008_bib0170","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13075-023-03059-x","article-title":"Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis","volume":"25","author":"Fairley","year":"2023","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"10.1016\/j.rceng.2024.02.008_bib0175","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1080\/07853890.2023.2179659","article-title":"Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease","volume":"55","author":"Jang","year":"2023","journal-title":"Ann Med."},{"key":"10.1016\/j.rceng.2024.02.008_bib0180","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.reuma.2022.10.003","article-title":"Description of a single centre cohort of patients with systemic sclerosis from the University Hospital of Buenos Aires and factors associated with lung function deterioration. A retrospective study","volume":"19","author":"Enghelmayer","year":"2023","journal-title":"Reumatol Clin."},{"issue":"7","key":"10.1016\/j.rceng.2024.02.008_bib0185","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1093\/rheumatology\/keac639","article-title":"Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort","volume":"62","author":"Ramahi","year":"2023","journal-title":"Rheumatology (Oxford)."}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2254887424000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T15:05:48Z","timestamp":1716649548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2254887424000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2254887424000316"],"URL":"https:\/\/doi.org\/10.1016\/j.rceng.2024.02.008","relation":{},"ISSN":["2254-8874"],"issn-type":[{"type":"print","value":"2254-8874"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rceng.2024.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2024.02.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}